Source comparison
MOTS-c for Mitochondrial Dysfunction Research: Full Comparison
Age-related metabolic decline AMPK activation restores glucose uptake and fatty acid oxidation independent of insulin signaling Preclinical models show 25–30% improvement in mitochondrial respiration; human trials ongoing Outperforms NAD+ precursors in insulin
This comparison does not assign a generated winner or score.
- Age-related metabolic decline
- AMPK activation restores glucose uptake and fatty acid oxidation independent of insulin signaling
- Preclinical models show 25–30% improvement in mitochondrial respiration; human trials ongoing
- Outperforms NAD+ precursors in insulin sensitivity improvement; comparable to exercise training in AMPK activation
- Strongest preclinical evidence exists for metabolic applications; mechanism well-characterized
- Insulin resistance models
- Increases GLUT4 translocation via insulin-independent pathway; reduces hepatic glucose output
- High-fat diet models show prevention of weight gain and preservation of glucose tolerance despite continued dietary stress
- Bypasses insulin receptor dysfunction that limits metformin efficacy; additive effect when combined with GLP-1 agonists in research models
- Mechanistic novelty is high; targets pathway distinct from existing diabetes therapeutics
- Mitochondrial quality control
- Enhances mitophagy (selective autophagy of damaged mitochondria) via AMPK-ULK1 pathway activation
- Demonstrated in aging models; reduces accumulation of dysfunctional mitochondria by ~40% compared to controls
- PQQ stimulates biogenesis but not removal of damaged units; MOTS-c addresses both generation and clearance
- Unique among mitochondrial interventions in directly improving organelle turnover
- Exercise capacity in aging
- Improves skeletal muscle oxidative capacity and reduces lactate accumulation during exertion
- 30% improvement in treadmill endurance in aged mice; mechanism involves increased mitochondrial enzyme activity
- Produces metabolic adaptations similar to endurance training without requiring physical activity
- Potential application for populations unable to exercise at therapeutic intensity
- Neuroprotection (preliminary)
- Crosses blood-brain barrier; reduces neuronal oxidative stress and supports synaptic mitochondrial function
- Early-stage research in neurodegenerative disease models; mechanism less defined than metabolic effects
- Antioxidants show limited CNS penetration; MOTS-c's peptide structure allows blood-brain barrier transit
- Promising but preliminary; requires further mechanistic study before clinical translation